Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Mutations in certain receptors can cause diseases and offer new treatment options.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

A new method accurately measures nine specific hormones in human blood.